ArticleInternational journal of clinical oncology2022

Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer.

Fedor V Moiseyenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.